Organogenesis Holdings (ORGO) Amortizatization of Intangibles (2018 - 2026)
Organogenesis Holdings (ORGO) recorded quarterly Amortizatization of Intangibles of $2.5 million in Q1 2026, down 57.23% quarter-over-quarter from $5.8 million in Q4 2025, and up 24.59% on a YoY basis from $2.0 million in Q1 2025.
Organogenesis Holdings (ORGO) Amortizatization of Intangibles (2018 - 2026) Analysis & Trends
Organogenesis Holdings' Amortizatization of Intangibles history runs 9 years deep, the most recent figure standing at $2.5 million for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles rose 24.59% year-over-year to $2.5 million; the TTM figure through Mar 2026 stood at $10.0 million (up 77.22% YoY), while the FY2025 annual figure was $8.3 million, changed 0.07% from the prior year.
- Amortizatization of Intangibles was $2.5 million for Q1 2026 at Organogenesis Holdings, down from $5.8 million in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $5.8 million in Q4 2025 to a low of $834000.0 in Q2 2024.
- Historically, Amortizatization of Intangibles has averaged $1.9 million across 5 years, with a median of $1.8 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles plunged 41.8% in 2023, then surged 195.13% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $3.6 million in 2022, then slumped by 41.8% to $2.1 million in 2023, then slipped by 6.98% to $2.0 million in 2024, then soared by 195.13% to $5.8 million in 2025, then plunged by 57.23% to $2.5 million in 2026.
- The last three Amortizatization of Intangibles figures came in at $2.5 million (Q1 2026), $5.8 million (Q4 2025), and $842000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | 1.30 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | 242,000.00 |
| 10 | Organogenesis Holdings | 318.21 Mn | 226.12 Mn | 11.46 Mn | 2.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.49 Mn |
| Mar 31, 2026 | 2.49 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Dec 31, 2025 | 5.82 Mn |
| Sep 30, 2025 | 842,000.00 |
| Sep 30, 2025 | 842,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Jun 30, 2025 | 841,000.00 |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 834,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 834,000.00 |
| Mar 31, 2024 | 2.20 Mn |
| Mar 31, 2024 | 2.20 Mn |
| Dec 31, 2023 | 2.12 Mn |
| Dec 31, 2023 | 2.12 Mn |